1 The FY 1988 request includes Amendments of +$8,880,000 for AIDS, -$2,357,000 for reduced FERS Agency contribution rate, and $33,800,000 proposed to be available from user fees.

² The FY 1989 request includes funding of $40,420,000 for AIDS-related work which was proposed to be funded in the AIDS Research and Education Account.

³ The FY 1989 appropriation does not include $5,000,000 added in the Anti-Drug Abuse Act.

⁴ The FY 1990 request includes $56,941,000 which was included in the proposed National HIV Program account, $13,900,000 requested as a supplemental appropriation, and $100,000,000 proposed to be available from user fees.

⁵ The FY 1990 appropriation includes $7,092,000 which was subsequently sequestered.

⁶ The FY 1991 request includes $157,175,000 proposed to be available from user fees.

⁷ The FY 1991 appropriation includes $8,868 which was subsequently sequestered.

⁸ The FY 1992 request includes $197,500,000 proposed to be available from user fees.

⁹ The FY 1993 appropriation request includes $200,000,000 proposed to be available from user fees.

¹⁰ The FY 1993 appropriation includes $1,900,000 to fund a clinical pharmacology pilot program; and a $3,000,000 supplemental for Mammography Quality Standards Act (MQSA) to be transferred from HCFA, NIH and CDC; and $36,000,000 for the Prescription Drug User Fee Act.

¹¹ The FY 1994 request includes $54,000,000 for the Prescription Drug User Fee Act (PDUFA); $64,600,000 for Investment Initiatives; $200,000,000 proposed to be available from User Fees.

¹² The FY 1994 appropriation includes $56,284,000 for PDUFA ($2,284 which was a supplemental appropriation), and $40,000,00 for Investment Initiatives.

¹³ The FY 1995 1995 request includes $79,423,000 for PDUFA; $24,000,000 for Device User Fees; $6,500,000 for MQSA fee collections; and other user fees of $228,000,000. Also included is a transfer from Office of the Secretary, Office of General Counsel to FDA of $2,745,000 and 34 FTE.

¹⁴ The FY 1995 appropriation includes an amended S&E BA of $817,681,000 and $79,423,000 for PDUFA. The amount does not include anticipated collections of MQSA inspections fees of $6,500,000. The level reflects the amended appropriation which rescinded $2,290,000.

¹⁵ The FY 1996 request includes S&E BA of $828,999,000; $84,723,000 for PDUFA; $13,000,000 for MQSA fee collections; $23,740,00 for MDUFA; and $15,000,000 for Import fees.

¹⁶ The FY 1996 appropriation includes S&E BA of $819,971,000; $84,723,000 for PDUFA; and $13,000,000 for MQSA fee collections.

¹⁷ The FY 1997 request includes S&E BA of $823,771,000; $87,528,000 for PDUFA; $13,403,000 for MQSA fee collections; $24,476,00 for MDUFA; and 15,000,000 for Import fees.

¹⁸ The FY 1997 appropriation includes S&E BA of $819,971,000; $87,528,000 for PDUFA; and $13,403,000 for MQSA fee collections.

¹⁹ The FY 1998 request includes S&E BA of $750,922,000; $91,204,000 for PDUFA; $13,966,000 for MQSA; $131,643,000 for new user fees. Does not reflect proposed PDUFA Supplemental request of $25,618,000 requested with the FY 1999 President's Budget.

²⁰ The FY 1998 appropriation includes S&E BA of $857,501,000; $91,204,000 for PDUFA; and $13,966,000 for MQSA fee collections.

²¹ The FY 1999 request includes S&E BA of $878,884,000; $132,273,000 for PDUFA; $14,385,000 for MQSA; and $127,717,000 for new user fees.

²² The FY 1999 House Action, Senate Action and Appropriation included the GSA Rent within the S&E Appropriation (BA of $82,866,000; PDUFA of $5,428,000).

²³ The FY 1999 appropriation includes S&E BA of $888,001,000; GSA Rent of $82,866,000 $132,273,000 for PDUFA; and $14,385,000 for MQSA fee collections.

²⁴ The FY 2000 appropriation includes S&E BA of $1,109,950,000 (including $94,537,000 of GSA Rent, $3,000,000 for Seafood Transfer); $145,434,000 for PDUFA; $14,817,000 for MQSA; $12,700,000 for Seafood Transfer User Fees, $17,000,000 for new user fees, and $13,400,000 for Bioterrorism.

²⁵ The FY 2001 request includes S&E of $1,156,905,000 (including $99,094,000 of GSA Rent); $149,273,000 for PDUFA; $15,128,000 for MQSA; $12,700,000 for Seafood Transfer User Fees, $1,500,000 for Export Certification; and $19,483,000 for new user fees (Food Additive $8,400,000; Premarket Medical Devices $5,833,000; Foods Export Certification $5,250,000).

¹ Does not reflect $333 which was subsequently sequestered.

² Includes $15,000,000 reserved for use by FDA for repairs and improvements to facilities.

³ Reflects a GSA rent reduction of $2,281,000 to the rent cap.

⁴ Includes an authorized reduction of GSA rent payments of $3,970,000 to cover FDA's Building Delegation expenses.

⁵ Includes an authorized reduction of GSA rent payments of $3,957,000 to cover FDA's Building Delegation expenses.

⁶ Includes an authorized reduction of GSA rent payments estimated to be $4,705,000 to cover FDA's Building Delegation expenses.

⁷ Includes an authorized reduction of GSA rent payments estimated to be $4,832,000 to cover FDA's Building Delegation expenses.

⁸ Includes an authorized reduction of GSA rent payments estimated to be $4,917,0000 to cover FDA's Building Delegation expenses and $5,428,000 of PDUFA collections.

⁸ In FY 1999, Congress included GSA Rent in the S&E Appropriation. Includes an authorized reduction of GSA rent payments estimated to be $4,917,0000 to cover FDA's Building Delegation expenses and $5,428,000 of PDUFA collections.

¹⁰ PDUFA collections of $5,643,000 are not included.

¹¹ PDUFA collections of $5,860,000 are not included.

¹ Funding of facilities projects - 1984 through 1992 - was included in the Program Expenses request but appropriated in this account.

² Does not include $200,000,000 provided to GSA in the Treasury, Postal Service, General Government Appropriation Act of 1992 for consolidation of FDA headquarters facilities.

³ Does not include $73,900,000 provided to GSA in the Treasury, Postal Service, General Government Appropriation Act of 1994 for consolidation of FDA headquarters facilities.

⁴ Does not include $45,000,000 provided to GSA in the Treasury, Postal Service, General Government Appropriation Act of 1995 for consolidation of FDA headquarters facilities.

⁵ Includes $9,800,000 to purchase land and begin engineering and design work for replacement of FDA's Los Angeles District office and laboratory.

⁶ Includes $3,800,000 for continuing work on an Arkansas Regional Laboratory at Jefferson, AR.

⁷ Includes $13,000,000 for continuing modernization of Arkansas Regional Laboratory at Jefferson, AR.

⁸ Includes $14,550,000 for continuing modernization of Arkansas Regional Laboratory at Jefferson, AR.

⁹ Includes $3,000,000 for continuing modernization of Arkansas Regional Laboratory at Jefferson, AR.

¹⁰ Includes $20,400,000 for construction of Phase I of the new Los Angeles Laboratory and $3,000,000 for continuing modernization of Arkansas Regional Laboratory at Jefferson, AR.

¹⁰ Includes $20,000,000 for construction of Phase I of the new Los Angeles Laboratory and $3,000,000 for continuing modernization of Arkansas Regional Laboratory at Jefferson, AR.

Edited 3/1/2000